|
시장보고서
상품코드
1901521
이식 진단 시장 : 제품 유형별, 기술별, 용도별, 최종 사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)Transplant Diagnostics Market by Product Type, By Technology, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032 |
||||||
이식 진단 시장 규모는 2024년에 62억 6,798만 달러로 평가되었으며, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 7.5%를 나타낼 전망입니다.
말기 장기 질환 증가에 따라 세계적으로 장기 이식 및 줄기 세포 이식 수술 건수가 증가하고 있는 것을 배경으로 세계 이식 진단(TD) 시장은 견조한 성장을 이루고 있습니다. 본 시장은 주로 기증자와 수령인의 적합성을 확보하고 이식편 거부 반응을 최소화하기 위해 인간 백혈구 항원(HLA) 타이핑, 항체 검출, 이식 후 모니터링에 초점을 맞추었습니다. 차세대 시퀀싱(NGS)과 기증자 유래 세포 유리 DNA(dd-cfDNA) 검사와 같은 기술 진보는 고해상도 매칭과 비침습적 거부 반응 모니터링을 제공함으로써 진단 풍경을 변화시키고 있습니다. 이러한 혁신적인 접근법은 환자 결과를 개선하고 병원 및 전문 검사 기관에서 진단 플랫폼의 임상적 유용성을 확대하고 있습니다. 고급 진단 플랫폼의 높은 비용과 지속적인 장기 부족은 여전히 주요 제약 요인이 되고 있습니다.
이식 진단 시장 역학
분자 분석에서 기술적 진보
기술적 진보가 최대의 추진력이 되고 있으며, 주로 혈청학적 검사나 PCR 기반 검사에서 고해상도 시퀀싱 기술로의 전환을 통해 실현되고 있습니다. 예를 들어, 2023년 10월에는 GenDx(미국)가 고해상도 HLA 타이핑을 변화시키는 차세대 솔루션인 NGS-Turbo를 도입했습니다. 이 제품은 옥스포드 나노포어 테크놀로지스의 시퀀싱 플랫폼을 활용하여 신속하고 정확하며 확장 가능한 타이핑 결과를 제공함으로써 턴어라운드 시간을 대폭 단축하고 이식 진단에서의 적합성 평가를 강화합니다. HLA 타이핑에 대한 차세대 시퀀싱(NGS) 도입은 알레르 수준에서 비교할 수 없는 분해능을 통해 기증자와 수령인의 보다 정확한 매칭을 실현하고, 이식편 대 숙주병(GVHD)과 거부 반응의 위험을 크게 줄이기 위해 매우 중요합니다. 게다가, 수용자 혈액에서 dd-cfDNA 정량과 같은 분자 분석을 이용한 비침습적 모니터링 기술의 개발은 동종이식편 손상의 조기적이고 신뢰성 있는 바이오마커를 제공하여 임상관리를 맞춤형 의료 전략으로 이끌어 냅니다. 이러한 동향은 이러한 첨단검사에 대한 연구개발자금 증가와 규제당국의 승인이 돌풍이 되어 가속하고 있습니다.
이식 진단 시장 : 세분화 분석
세계의 이식 진단 시장은 제품 유형, 기술, 용도, 최종 사용자 및 지역에 따라 세분화됩니다.
제품 유형에 따른 시장 내역은 다음 세 가지 카테고리입니다. 시약, 소모품, 장비, 소프트웨어 및 서비스. 이식 수술 건수의 많음과 전문적인 HLA 타이핑 키트, 검출용 항체, 핵산 추출 시약의 지속적인 수요에 의해 시약 및 소모품 부문이 최대의 점유율을 차지하고 있습니다.
기술별로는 분자 검정과 비분자 검정(기타)의 2대 범주로 분류됩니다. PCR 기반 및 시퀀싱 기반(NGS, Sanger 방법) 기술을 포함한 분자 분석은 복잡한 HLA 대립 유전자의 해명에 필수적인 우수한 정확성과 높은 처리량 능력으로 시장을 독점하고 있습니다. 비분자 분석에는 혈청학 검사 및 혼합 림프구 배양(MLC) 검사가 포함됩니다.
시장은 용도에 따라 진단 용도(이식 전 진단, 이식 후 모니터링), 연구 용도 등으로 분류됩니다. 진단 용도는 이식 전의 적합성 검사가 의무화되어 있기 때문에 주요 부문이 되었습니다.
최종 사용자를 기반으로 하는 시장 내역은 다음 3가지입니다. 병원·이식 센터, 진단실험실, 연구소 등. 독립형 레퍼런스 랩을 포함한 진단 실험실은 대량 처리 능력과 복잡한 분자 검사에 있어서의 전문적인 지견에 의해 큰 점유율을 차지하고 있습니다.
이식 진단 시장 - 지역별 분석
북미는 고급 의료 인프라, 선진 진단 기술에 대한 높은 인지도, 특히 신장·심장 이식을 중심으로 한 다수의 이식 수술 건수에 의해 최대 시장 점유율을 차지하고 있습니다. 유럽은 표준화된 장기 공유 프로그램(유로 트랜스플란트 등)과 의료 연구에 대한 강력한 공적 자금 지원으로 비침습적 모니터링 시스템의 조기 도입이 촉진되어 북미에 이은 규모가 되고 있습니다. 아시아태평양(APAC)지역은 의료지출의 급속한 증가, 만성질환의 발생률 상승, 특히 중국과 인도 등 국가에서 장기제공 프로그램을 지원하는 정부 정책의 진전에 의해 가장 급속한 성장이 예상되는 시장입니다. 라틴아메리카(LATAM) 및 중동 및 아프리카(MEA) 지역은 의료 시스템의 분단화와 기술비용이 높아 성장이 완만하지만 꾸준한 성장을 보이고 있으며 전략적인 정부 투자가 시장 기회를 창출하기 시작하고 있습니다.
이식 진단 시장 - 국가별 분석
중국은 엄청난 인구 규모와 장기 제공 시스템의 최근 규제 측면에서 큰 진전으로 높은 잠재력을 지닌 시장이 될 전망입니다. 이 나라에서는 자발적인 시체 제공 프로그램이 크게 확대되어 이식 건수 증가와 이에 따른 정확한 이식 진단에 대한 수요 급증으로 이어지고 있습니다. 주요 촉진요인으로는 병원 인프라의 현대화를 위한 정부의 이니셔티브, 국내 분자진단 연구 개발에 대한 대규모 투자, 자동화된 고처리량 HLA 타이핑 시스템의 도입 확대(대부분은 현지 제조 또는 현지 적응형)를 들 수 있습니다. 그러나 다양한 지역 병원간에 검사 프로토콜을 표준화하고 복잡한 차세대 시퀀싱(NGS) 데이터를 해석하는 데 필요한 고급 전문 인력 부족을 해결하는 등 시장에는 과제도 존재합니다. 시장 진출 전략으로는 규제 프레임워크을 준수하기 위해 현지 파트너와의 제휴가 종종 채용되고 있습니다.
목차
제1장 이식 진단 시장 개요
- 분석 범위
- 시장 추정 연도
제2장 주요 요약
- 시장 분석
- 경쟁 인사이트
제3장 이식 진단의 주요 시장 동향
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 시장 전망 동향
제4장 이식 진단 시장 : 산업 분석
- PEST 분석
- Porter's Five Forces 분석
- 시장 성장 전망 : 매핑
- 규제 체계 분석
제5장 이식 진단 시장 : 높아지는 지정학적 긴장의 영향
- COVID-19 팬데믹의 영향
- 러시아·우크라이나 전쟁의 영향
- 중동 분쟁의 영향
제6장 이식 진단 시장 상황
- 이식 진단 시장 점유율 분석(2024년)
- 주요 제조업체별 분석 데이터
- 기존 기업 분석
- 신생 기업 분석
제7장 이식 진단 시장 : 제품 유형별
- 개요
- 부문 점유율 분석 : 제품 유형별
- 시약 및 소모품
- 기기
- 소프트웨어 및 서비스
- 기타
제8장 이식 진단 시장 : 기술별
- 개요
- 부문 점유율 분석 : 기술별
- 분자 검사법
- PCR 기반 검사법
- 시퀀싱 기반 검사법(NGS, Sanger)
- 비분자 검사법
- 혈청학적 검사법
- 혼합 림프구 배양(MLC)
- 기타
제9장 이식 진단 시장 : 용도별
- 개요
- 부문별 점유율 분석 : 용도별
- 진단 용도
- 이식 전 진단(HLA 타이핑, 교차 검사)
- 이식 후 모니터링(거부반응 및 감염)
- 연구 용도
- 기타
제10장 이식 진단 시장 : 최종 사용자별
- 개요
- 부문별 점유율 분석 : 최종 사용자별
- 병원 및 이식 센터
- 진단 실험실(독립 참조 실험실)
- 연구 및 학술 기관
- 기타
제11장 이식 진단 시장 : 지역별
- 서론
- 북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
- 유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 네덜란드
- 스웨덴
- 러시아
- 폴란드
- 기타
- 아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 중국
- 인도
- 일본
- 한국
- 호주
- 인도네시아
- 태국
- 필리핀
- 기타
- 라틴아메리카(LATAM)
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
- 중동 및 아프리카(MEA)
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 튀르키예
- 알제리
- 이집트
- 기타
제12장 주요 공급업체 분석 : 이식 진단 업계
- 경쟁 대시보드
- 경쟁 벤치마킹
- 경쟁 포지셔닝
- 기업 프로파일
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- CareDx, Inc.
- Immucor, Inc.(part of Werfen)
- Illumina, Inc.
- Qiagen NV
- F. Hoffmann-La Roche AG
- Abbott Laboratories
- Omixon Ltd.
- Eurofins Scientific SE
- Others
제13장 애널리스트의 전방위적 전망
KTHThe Transplant Diagnostics Market size was valued at US$6,267.98 Million in 2024, expanding at a CAGR of 7.5% from 2025 to 2032.
The global Transplant Diagnostics (TD) market is experiencing robust growth driven by the rising number of organ and stem cell transplantation procedures worldwide due to the increasing prevalence of end-stage organ diseases. The market primarily focuses on Human Leukocyte Antigen (HLA) typing, antibody detection, and post-transplant monitoring to ensure donor-recipient compatibility and minimize graft rejection. Technological advancements, particularly in Next-Generation Sequencing (NGS) and donor-derived cell-free DNA (dd-cfDNA) testing, are transforming the diagnostic landscape by offering high-resolution matching and non-invasive rejection monitoring. These innovative approaches are improving patient outcomes and expanding the clinical utility of diagnostic platforms across hospitals and specialized reference laboratories. The high cost of advanced diagnostic platforms and a persistent organ shortage remain key constraints.
Transplant Diagnostics Market- Market Dynamics
Technological Advancements in Molecular Assays
Technological progress is the paramount driver, primarily through the shift from serological and PCR-based assays to high-resolution sequencing technologies, for instance, On October 2023, GenDx (U.S.) introduced NGS-Turbo, a next-generation solution designed to transform high-resolution HLA typing. The launch leverages Oxford Nanopore Technologies' sequencing platforms to deliver rapid, accurate, and scalable typing results, significantly improving turnaround time and enhancing compatibility assessment in transplant diagnostics. The adoption of Next-Generation Sequencing (NGS) for HLA typing is critical as it offers unparalleled resolution at the allele level, leading to more accurate donor-recipient matching and significantly reducing the risk of graft-versus-host disease (GVHD) and rejection. Furthermore, the development of non-invasive monitoring using molecular assays, such as quantifying dd-cfDNA in the recipient's blood, provides an early, reliable biomarker for allograft injury, moving clinical management towards personalized medicine strategies. This trend is accelerated by increasing R&D funding and favorable regulatory approvals for these cutting-edge tests.
Transplant Diagnostics Market- Segmentation Analysis:
The Global Transplant Diagnostics Market is segmented on the basis of Product Type, Technology, Application, End-user, and Region.
The market is divided into three categories based on Product Type: Reagents & Consumables, Instruments, and Software & Services. The Reagents & Consumables segment holds the largest share due to the high volume of transplant procedures and the recurring need for specialized HLA typing kits, detection antibodies, and nucleic acid extraction reagents.
The market is divided into two major categories based on Technology: Molecular Assays and Non-Molecular Assays and others. Molecular Assays, encompassing PCR-based and Sequencing-based (NGS, Sanger) methods, dominate the market due to their superior accuracy and high throughput capability essential for resolving complex HLA alleles. Non-Molecular Assays include Serology and Mixed Lymphocyte Culture (MLC) tests.
The market is divided into two categories based on Application: Diagnostic Applications (Pre-transplant Diagnostics, Post-transplant Monitoring) , Research Applications and others. Diagnostic applications are the dominant segment, driven by mandatory pre-transplant compatibility testing.
The market is divided into three categories based on End-user: Hospitals & Transplant Centers, Diagnostic Laboratories, and Research & Academic Institutes and others. Diagnostic Laboratories, including independent reference labs, hold a substantial share due to their high-volume processing capabilities and specialized expertise in complex molecular assays.
Transplant Diagnostics Market- Geographical Insights
North America commands the largest market share, attributable to its sophisticated healthcare infrastructure, high awareness of advanced diagnostic technologies, and a large number of transplant procedures, especially kidney and heart transplants. Europe follows closely, driven by standardized organ sharing programs (like Eurotransplant) and robust public funding for healthcare research, promoting early adoption of non-invasive monitoring systems. The Asia Pacific (APAC) region is projected to be the fastest-growing market, fuelled by rapid improvements in healthcare spending, an increasing incidence of chronic diseases, and evolving government policies that support organ donation programs, particularly in countries like China and India. LATAM and MEA regions exhibit slower, steady growth, primarily constrained by fragmented healthcare systems and high technology costs, though strategic governmental investments are beginning to create market opportunities.
Transplant Diagnostics Market- Country Insights
China is poised to be a high-potential market due to its sheer population size and the significant recent regulatory advancements in its organ donation system. The country has substantially increased its voluntary deceased donor program, leading to a rise in transplant volumes and a corresponding spike in the demand for accurate transplant diagnostics. Key drivers include government initiatives to modernize hospital infrastructure, massive investments in domestic molecular diagnostics R&D, and the increasing adoption of automated, high-throughput HLA typing systems, often locally manufactured or adapted. However, the market faces challenges related to standardizing testing protocols across diverse regional hospitals and addressing the shortage of highly specialized personnel required to interpret complex NGS data. Market entry strategies often involve local partnerships to navigate regulatory frameworks.
Transplant Diagnostics Market- Competitive Landscape:
The global transplant diagnostics market is highly competitive and moderately consolidated, dominated by key players such as Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., CareDx, Inc., Immucor, Inc. (part of Werfen), Illumina, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Abbott Laboratories, Omixon Ltd., and Eurofins Scientific SE. These companies focus heavily on molecular assay platforms, where competition centers around the resolution and speed of HLA typing, sensitivity of antibody detection, and the development of non-invasive graft rejection monitoring tools like dd-cfDNA. Key strategies include Mergers & Acquisitions (M&A) to acquire novel technologies, notably the integration of bioinformatics software for enhanced data interpretation. Companies are aggressively pursuing strategic collaborations with major transplant centers and reference laboratories to expand their product penetration and establish clinical validation for new assays. A prominent trend is the shift towards integrated solutions that combine instruments, reagents, and analytical software into a single, seamless workflow for improved lab efficiency. For example, in October 2025, a leading diagnostics firm acquired a specialized AI-driven platform provider to enhance predictive modeling for post-transplant infection risk.
Recent Developments:
On February 2025, Pirche AG (Germany) entered into a strategic partnership with Devyser AB (Sweden) to advance next-generation transplant diagnostics. The collaboration focuses on integrating Pirche's AI-driven TxPredictor Platform-designed for immune profiling and risk prediction-with Devyser's portfolio of novel biomarkers to enable more personalized monitoring in transplant patients. This combined approach aims to enhance clinical decision-making by improving compatibility assessment, early rejection detection, and overall transplant outcomes.
On May 2024, Thermo Fisher Scientific launched a CXCL10 testing service developed for kidney transplant patients. This advanced assay enables rapid detection of the CXCL10 chemokine, offering faster results compared to currently used diagnostic methods. By improving early identification of inflammatory activity and potential rejection, the service enhances clinical decision-making and supports more effective post-transplant monitoring.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL TRANSPLANT DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- CareDx, Inc.
- Immucor, Inc. (part of Werfen)
- Illumina, Inc.
- Qiagen N.V.
- F. Hoffmann-La Roche AG
- Abbott Laboratories
- Omixon Ltd.
- Eurofins Scientific SE
- Others
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY PRODUCT TYPE - MARKET ANALYSIS, 2019 - 2032
- Reagents & Consumables
- Instruments
- Software & Services
- Others
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY TECHNOLOGY - MARKET ANALYSIS, 2019 - 2032
- Molecular Assays
- PCR-based Assays
- Sequencing-based Assays (NGS, Sanger)
- Non-Molecular Assays
- Serological Assays
- Mixed Lymphocyte Culture (MLC)
- Others
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
- Diagnostic Applications
- Pre-transplant Diagnostics (HLA Typing, Cross-matching)
- Post-transplant Monitoring (Rejection/Infection)
- Research Applications
- Others
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY END-USER - MARKET ANALYSIS, 2019 - 2032
- Hospitals & Transplant Centers
- Diagnostic Laboratories (Independent Reference Labs)
- Research & Academic Institutes
- Others
GLOBAL TRANSPLANT DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Transplant Diagnostics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Transplant Diagnostics Market Snippet by Product Type
- 2.1.2. Transplant Diagnostics Market Snippet by Technology
- 2.1.3. Transplant Diagnostics Market Snippet by Application
- 2.1.4. Transplant Diagnostics Market Snippet by End-user
- 2.1.5. Transplant Diagnostics Market Snippet by Country
- 2.1.6. Transplant Diagnostics Market Snippet by Region
- 2.2. Competitive Insights
3. Transplant Diagnostics Key Market Trends
- 3.1. Transplant Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Transplant Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Transplant Diagnostics Market Opportunities
- 3.4. Transplant Diagnostics Market Future Trends
4. Transplant Diagnostics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Transplant Diagnostics Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Transplant Diagnostics Market Landscape
- 6.1. Transplant Diagnostics Market Share Analysis, 2024
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Transplant Diagnostics Market - By Product Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024&2032 (%)
- 7.1.2. Reagents & Consumables
- 7.1.3. Instruments
- 7.1.4. Software & Services
- 7.1.5. Others
8. Transplant Diagnostics Market - By Technology
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology, 2024&2032 (%)
- 8.1.2. Molecular Assays
- 8.1.2.1. PCR-based Assays
- 8.1.2.2. Sequencing-based Assays (NGS, Sanger)
- 8.1.3. Non-Molecular Assays
- 8.1.3.1. Serological Assays
- 8.1.3.2. Mixed Lymphocyte Culture (MLC)
- 8.1.4. Others
9. Transplant Diagnostics Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
- 9.1.2. Diagnostic Applications
- 9.1.2.1. Pre-transplant Diagnostics (HLA Typing, Cross-matching)
- 9.1.2.2. Post-transplant Monitoring (Rejection/Infection)
- 9.1.3. Research Applications
- 9.1.4. Others
10. Transplant Diagnostics Market - By End-user
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
- 10.1.2. Hospitals & Transplant Centers
- 10.1.3. Diagnostic Laboratories (Independent Reference Labs)
- 10.1.4. Research & Academic Institutes
- 10.1.5. Others
11. Transplant Diagnostics Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Transplant Diagnostics Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Transplant DiagnosticsKey Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.13.6. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.3.17. Rest of Europe
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Transplant DiagnosticsKey Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.4.15.3. PhilippinesMarket Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Transplant Diagnostics Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Transplant DiagnosticsKey Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.6.9. UAE
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.6.9.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.6.9.4. UAE Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.6.9.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.6.9.6. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Billion)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Billion)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Billion)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Billion)
12. Key Vendor Analysis- Transplant Diagnostics Industry
- 12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. Thermo Fisher Scientific Inc.
- 12.2.2. Bio-Rad Laboratories, Inc.
- 12.2.3. CareDx, Inc.
- 12.2.4. Immucor, Inc. (part of Werfen)
- 12.2.5. Illumina, Inc.
- 12.2.6. Qiagen N.V.
- 12.2.7. F. Hoffmann-La Roche AG
- 12.2.8. Abbott Laboratories
- 12.2.9. Omixon Ltd.
- 12.2.10. Eurofins Scientific SE
- 12.2.11. Others
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
